Published in Blood Weekly, October 20th, 2005
S. Mohammadi and coauthors working at Hopital la Pitie-Salpetriere in Paris "conducted a retrospective review of patients after heart transplantation to investigate the prevalence, treatment, and outcome of prostate cancer diagnosed after systematic screening (study group)," compared with "case-matched HTR (control)."
"Among 702 recipients, 15 patients had elevated prostate-specific antigen (PSA) levels,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.